Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep versus moderate neuromuscular blockade during laparoscopic donor nephrectomy
NL-OMON42929Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rocuronium and Sugammadex (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Quality of Recovery-40 score at 24 hours after extubation. Started Nov 2016; status: active, not recruiting.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on NL-OMON42929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42929.